Journal profile · Medicine-Urology
Frontiers in Urology
ISSN 2673-9828 · Frontiers Media S.A. · Switzerland
Frontiers in Urology: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 1.7 (journal website); fully open access; APC charged, amount not published; median 72 days to acceptance (94 articles, last 24 months); 36 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Frontiers in Urology is published by Frontiers Media S.A. and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Urinary Bladder and Prostate Research, Urological Disorders and Treatments and Bladder and Urothelial Cancer Treatments, together about 28.7% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Frontiers in Urology is a multidisciplinary journal advancing urological health insights through new approaches for better patient outcomes. Led by Field Chief Editor Darius Bagli (Hospital for Sick Children, University of Toronto, Canada), this journal covers new developments in urology, spanning from disease mechanisms to clinical care, surgery, prevention, and population health research. Topics include, but are not limited to: andrology and male infertility calculus disease developmental, pediatric, and adolescent urology which mirrors many of these spheres in the pre-adult, and itself is evolving similar sub-themes functional urology, including non- cancer urinary tract health and disease urogynecology urooncology. Frontiers in Urology encourages studies addressing the following areas: expanding research on fundamental biological, genetic, epigenetic, and molecular disease mechanisms through clinical and surgical care guidelines, approaches, therapies, and techniques, as well as disease prevention and population health research, including social determinants of health, quality of life, and patient-reported outcomes fundamental translational research on biological, genetic, epigenetic, and molecular disease mechanisms as they relate to urological and allied conditions. This includes consideration of gene-environmental interactions relevant to urologic conditions studies that harness and advance the roles of the burgeoning areas of artificial intelligence, big data, EMR data, and deep learning will be of particular interest to the journal across all spheres of Urology in the coming years uro-surgical technology, including endourology, robotics, minimally invasive approaches, and basic and translational scientific research. This journal also welcomes submissions that support the advancement of the UN’s Sustainable Development Goals (SDGs), notably SDG 3: good health and well-being. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Frontiers in Urology is committed to developing urology research by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public, enabling future scientific breakthroughs. Frontiers in Urology is a member of the Committee on Public
From the journal's Aims & Scope
Research area (LetPub): Medicine-Urology
Editorial board by country: none in mainland China; most named United States 9, Italy 3, Canada 1, Netherlands 1, Brazil 1 (16 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Urinary Bladder and Prostate ResearchMedicine11.1%
- Urological Disorders and TreatmentsMedicine8.9%
- Bladder and Urothelial Cancer TreatmentsMedicine8.7%
- Prostate Cancer Diagnosis and TreatmentMedicine8.5%
- Pelvic floor disorders treatmentsMedicine6.6%
- Kidney Stones and Urolithiasis TreatmentsMedicine6.4%
- Pediatric Urology and Nephrology StudiesMedicine5.3%
- Prostate Cancer Treatment and ResearchMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 2.2LetPub ·
- CiteScore (publisher)
- 2.2Publisher website ·
- SJR 2026-06
- 0.38LetPub ·
- SNIP 2026-06
- 0.55LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 23OpenAlex ·
- 2-year mean citedness
- 1.33OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 31LetPub ·
Articles by year OpenAlex count · 265 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 61 | 61 | 14 |
| 2025 | 36 | 36 | 58 |
| 2024 | 25 | 25 | 90 |
| 2023 | 73 | 73 | 350 |
| 2022 | 68 | 68 | 244 |
| 2021 | 2 | 2 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
72 daysMedian, submission to acceptance · P25–P75 45 days – 112 days
- Acceptance to online
- median 23 days (94 articles)
- Submission to online
- median 97 days
- Sample
- 94 articles with submission and acceptance dates (96 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 2,125 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Article types accepted2
- clinical trialClinical Trial articlesLength not stated
- original researchOriginal Research articlesLength not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images published under CC-BY license; permission required for copyrighted material. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under CC-BY license (version 4.0) for all articles from July 2012 onwards. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Manuscripts must meet international English language standards. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Frontiers Media S.A.
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2673-9828
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Frontiers in Urology
What CAS zone is Frontiers in Urology in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Frontiers in Urology?
The journal's website gives an impact factor of 1.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.2, h-index 12.
How long does peer review take at Frontiers in Urology?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 45–112 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Frontiers in Urology?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Frontiers in Urology based?
Of the 16 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (9), Italy (3) and Canada (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Frontiers in Urology?
According to LetPub and DOAJ records, Frontiers in Urology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science and PMC; that list has not been checked against each database.
Is Frontiers in Urology open access, and what is the APC?
Frontiers in Urology is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .